Condition category
Musculoskeletal Diseases
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status
Results overdue

Plain English Summary

Not provided at time of registration

Trial website

Contact information



Primary contact

Prof Philippe Gaudin


Contact details

Department of Rheumatology
Hôpital Sud
Grenoble Teaching Hospital
Avenue de Kimberley
BP 338

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title



Study hypothesis

The dynamic exercise programme improves quality of life in rheumatoid arthritis (RA) patients

Ethics approval

Ethics Committee for Protection of Human Subjects in Biomedical Research (Comités de Consultation pour la Protection des Personnes se prêtant à la Recherche Biomédicale [CCPPRB]), Grenoble II. Date of approval: 11/12/2002

Study design

Prospective, single-blind, randomised controlled trial

Primary study design


Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type


Patient information sheet


Rheumatoid arthritis


Roeder manipulative aptitude test, five-handle position grip test and grip and pinch strength test were carried out at baseline to avoid discrepancy in term of patients' skill between the two groups.

The dynamic exercise program was consistent with the 1990 recommendation of the American College of Sports Medicine. Three or four members of the medical staff (rheumatologist, physiotherapist or occupational therapist) took part in each session for 5 hours a day during a 4 week period. During the first week, patients benefited from hydrotherapy and occupational therapy input. Knowledge of the disease and physical capacity was evaluated for each participant in order to design, after multidisciplinary co-ordination, a patient-specific exercise program. The second week of the program focused on the influence of RA on daily activities. Muscle strengthening against resistance (of pain-free joints) replaced the hydrotherapy. The occupational therapy program in the third week included skill exercises and daily activities with increasing difficulty (endurance and exercises against resistance). During the forth week the exercises focused on office tasks. Pain and fatigue were prevented by regular breaks and relaxation in order to improve pain tolerance and self-esteem.

Patients allocated to control group had usual care physical therapy according to French recommendations. Briefly, standard joint rehabilitation consisted of interactive lessons taught by rheumatologists, physiotherapists or occupational therapists and meetings for groups of 3 to 4 patients over the course of three days. Occupational therapy advices (verbal information, short movies, booklet) were given and splints were designed to prevent joint deformation and to help patients in daily living tasks.

Intervention type



Not Specified

Drug names

Primary outcome measure

Functional status, evaluated by the Health Assessment Questionnaire (HAQ) at 1 and 6 months and 1 year. HAQ total score ranges from 0 (no functional limitation) to 3 (dramatic functional impairment).

Secondary outcome measures

The following were assessed at 1, 6 and 12 months:
1. Functional, clinical, radiological, therapeutic and biological modifications in both groups using the following tools:
1.1. The French version of Arthritis Impact Score 2- short form (AIMS2-SF) is a specific questionnaire to assess quality of life in RA patients. AIMS2-SF was not converted to a score of 0 to 10 but was expressed on a scale from 0 to 50.
1.2. Nottingham Health Profile (NHP) is a 38 item generic health-related quality of life measure (range 0 to 600, higher score for greater health problems)
2. Patient dexterity, evaluated by occupational therapists using Sequential Occupational Dexterity Assessment (SODA) or self reported by patients using Duruoz Hand Index (DHI) and a self report questionnaire.
2.1. SODA consists of 12 standardized tasks evaluated by occupational therapists and ranges from 0 to 108.
2.2. The purpose of DHI (range 0-90) was to measure hand ability while performing personal hygiene, office tasks and other general activities
3. Simple Erosions Narrowing Score (SENS, range 0-86) considers erosions in 32 joints in the hands and 12 in the feet, and joint space narrowing in 30 and 12 joints respectively. The total SENS score was assessed by a single radiologist unaware of the group assignment.
4. Disease activity was determined using Disease Activity Score (DAS 28, range 0.14-9.3). A 28 joint count for swelling and tenderness was assessed by a rheumatologist unaware of the treatment allocation. Patients rated their general health on a 100 mm visual analogue scale. DAS 28 was calculated using the three previously mentioned parameters and Erythrocyte Sedimentation Rate (ESR).
5. Aerobic capacity was measured on an exercise bike as the distance covered in 5 minutes.
6. Use of oral and intra-articular drug, as well as other medical devices were recorded

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. 1987 modified American College of Rheumatology (ACR) criteria for RA
2. Treated with a disease-modifying anti-rheumatic drug

Participant type


Age group




Target number of participants


Participant exclusion criteria

1. >10 mg glucocorticoid per day
2. No or unstable Disease Modifying Anti-Rheumatic Drug (DMARD) regimen
3. DAS28 variation >1.2 in the past 3 months
4. Age <18 or >70
5. Severe comorbidity causing a reduced life expectancy
6. Global functional status in RA class III or IV
7. Patients unable to follow the educational program or complete a questionnaire because of cognitive impairment, psychiatric disease, social frailty or language difficulty

Recruitment start date


Recruitment end date



Countries of recruitment


Trial participating centre

Department of Rheumatology

Sponsor information


Association for Research on Osteoarticular Disease (ARPOA) (France)

Sponsor details

Department of Rheumatology
Hôpital Sud
Grenoble Teaching Hospital
Avenue de Kimberley
BP 338

Sponsor type

Research organisation



Funder type

Research organisation

Funder name

Association for Research on Osteoarticular Disease (Association de Recherche en Pathologie Ostéo-Articulaire; ARPOA) (France)

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes